Next up for CRISPR: Gene editing for the masses?

14Report
Next up for CRISPR: Gene editing for the masses?

Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.

Similar news

Share
Report

Report this article here.